ICD 10 CM C51.9 | Description & Clinical Information

ICD 10 C51.9 describes a type of cancerous growth that occurs in the external genital organs of a female, known as the vulva, which is characterized by the abnormal multiplication of vulvar cells that can rapidly spread to nearby tissues, blood vessels or lymphatic vessels, and is associated with various risk factors such as older age, human papillomavirus (HPV) infections, smoking, and a weak immune system, while the specific part of the vulva affected is not documented by the provider.

Official Description Of C51.9

The ICD 10 CM book defines ICD 10 code C51.9 as:

When To Use C51.9

The diagnosis described by the ICD 10 CM C51.9 code is malignant neoplasm of the vulva. This is a cancerous growth that affects the external female genitalia. It is a rare type of cancer that can occur in women of all ages, but it is more common in postmenopausal women. The condition can be asymptomatic, which means that patients can have the disease without knowing it. However, in some cases, cancerous growths can cause physical symptoms that may indicate the presence of a malignancy.

Patients with malignant neoplasm of the vulva may experience a range of symptoms. One of the most common symptoms is skin thickening in the affected area. This can lead to soreness and discomfort during movement. Additionally, patients may experience a wart-like growth or lump in the affected area. This growth can be tender to the touch and may be accompanied by pain while urinating.

Other symptoms of malignant neoplasm of the vulva include pain during intercourse, chronic itching, and excessive scratching, which can lead to bleeding. These symptoms may be due to the presence of ulcers or sores that do not heal. As the cancer progresses, it can spread to nearby tissues through lymph nodes and blood vessels. If the cancer is not detected early, it can be fatal.

To diagnose this disease, healthcare providers rely on several tools. These include the patient’s medical history, symptoms, and a gynecological examination. Cystoscopy and proctoscopy may also be performed to check advanced cases of vulvar cancer which may have spread to the rectum, bladder or other pelvic organs. In some cases, imaging tests such as X-rays, computerized tomography (CT) scans, magnetic resonance imaging (MRI), and positron emission tomography (PET) may be used to confirm the diagnosis and stage the malignancy.

Once diagnosed, treatment depends on the stage of the cancer. In general, the treatment for malignant neoplasm of the vulva involves a combination of chemotherapy, radiation therapy, and surgery. Surgery may involve partial or complete vulvectomy or removal of nearby lymph nodes. Treatment options depend on the extent of the disease and the patient’s overall health status.

In conclusion, malignant neoplasm of the vulva is a rare type of cancer that can affect women of all ages. Patients may experience a range of symptoms, including skin thickening, soreness, a wart-like growth or lump, and pain while urinating. If left untreated, the cancer can progress and be fatal. To diagnose the disease, healthcare providers rely on the patient’s medical history, symptoms, and a gynecological examination. Imaging tests may also be necessary to confirm and stage the malignancy. Treatment options depend on the extent of the disease and the patient’s overall health status.